Nab-paclitaxel Combined with Bevacizumab in the Treatment of Metastatic Extrapulmonary Neuroendocrine Carcinoma
Clinical trial NCT04705519 · COMPLETED
Trial details
- NCT number
- NCT04705519
- Sponsor
- Peking University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-05
- Primary completion
- 2024-09-30
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.